Used in pharmaceutical research as a potential kinase inhibitor, particularly investigated for its activity in signaling pathways related to cancer progression. Shows promise in preclinical studies for targeting specific tyrosine kinases involved in tumor growth and cell proliferation. Also explored for anti-inflammatory properties due to its ability to modulate cellular responses in immune-related diseases. Its structure supports high selectivity and binding affinity, making it a candidate for development in targeted therapies. Not approved for clinical use; currently limited to laboratory and experimental settings.